Clinical Trial Update: Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating perioperative oxaliplatin with S-1 in combination with Helicobacter pylori eradication for locally advanced gastric cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Chemotherapy Effect | Phase 2 | Status: RECRUITING